Viselli S M, Mastro A M
Department of Molecular and Cell Biology, Pennsylvania State University, University Park 16802.
Endocrinology. 1993 Feb;132(2):571-6. doi: 10.1210/endo.132.2.8425477.
An increasingly large body of evidence implicates PRL as an immunoregulatory molecule. While most of the data relate to PRL levels and immunocompetence in vivo, we have shown that PRL is mitogenic for splenocytes from ovariectomized rats and rats in certain other hormonal states. This finding suggests that these lymphocytes express PRL receptors. Here, we wished to determine whether all or only a subset of splenocytes were PRL receptor positive. By using polyclonal as well as monoclonal antibodies to PRL receptor, we determined that as many as 20% of the primary splenocytes expressed PRL receptors. In a culture of Nb2 cells, a PRL receptor-positive lymphoid line, as many as 70% were PRL receptor positive. Dual labeling for lymphoid-specific antigen surface markers and PRL receptor indicated that about one third of the PRL receptor-positive splenocytes were kappa-light chain-positive B-cells, while the others stained with antibodies to T-cell markers, CD4 or CD8. These data confirm that lymphocytes express PRL receptors and show for the first time that PRL receptor-positive lymphocytes are a heterogenous subset of total primary splenocytes. These cells may be the target for PRL-mediated immunoregulation.
越来越多的证据表明催乳素(PRL)是一种免疫调节分子。虽然大多数数据涉及体内PRL水平和免疫能力,但我们已经表明,PRL对去卵巢大鼠和处于某些其他激素状态的大鼠的脾细胞具有促有丝分裂作用。这一发现表明这些淋巴细胞表达PRL受体。在这里,我们希望确定是所有脾细胞还是只有一部分脾细胞是PRL受体阳性。通过使用针对PRL受体的多克隆抗体和单克隆抗体,我们确定多达20%的原代脾细胞表达PRL受体。在PRL受体阳性的淋巴样细胞系Nb2细胞培养物中,多达70%的细胞是PRL受体阳性。对淋巴特异性抗原表面标志物和PRL受体进行双重标记表明,约三分之一的PRL受体阳性脾细胞是κ轻链阳性B细胞,而其他细胞则与T细胞标志物CD4或CD8的抗体发生染色。这些数据证实淋巴细胞表达PRL受体,并首次表明PRL受体阳性淋巴细胞是原代脾细胞总数中的一个异质亚群。这些细胞可能是PRL介导的免疫调节的靶标。